<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e> and hypochondroplasia are <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo> of <z:hpo ids='HP_0000006'>autosomal dominant inheritance</z:hpo> that represent different degrees of severity of the same pathological entity </plain></SENT>
<SENT sid="1" pm="."><plain>Both <z:mpath ids='MPATH_589'>dysplasias</z:mpath> are caused by mutations in the Fibroblast Growth Factor Receptor 3 (FGFR3) gene </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> more than 95% of the cases studied to date carry the same mutation (G380R) </plain></SENT>
<SENT sid="3" pm="."><plain>Hypochondroplasia represents a greater clinical and <z:hpo ids='HP_0001425'>genetic heterogeneity</z:hpo>, possibly being confused with "idiopathic <z:hpo ids='HP_0004322'>short stature</z:hpo>" </plain></SENT>
<SENT sid="4" pm="."><plain>The N540K mutation has been detected in 50-70% of cases of hypochondroplasia and mutations at the 650 locus in approximately 2.8% </plain></SENT>
<SENT sid="5" pm="."><plain>AIM: To assess the frequency of N540K and G380R mutations, and changes at the 650 locus in Chilean patients with idiopathic <z:hpo ids='HP_0003498'>disproportionate short stature</z:hpo>, hypochondroplasia and <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>PATIENTS AND METHODS: We studied 21 patients referred for idiopathic <z:hpo ids='HP_0004322'>short stature</z:hpo>, 5 with clinically suspected hypochondroplasia and 4 with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The G1138A, G1138C (G380R), and C1620, C1620A (N540K) mutations and the nucleotide changes at the 650 locus were studied using PCR and restriction analysis of genomic DNA </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Three out of five hypochondroplasia patients were heterozygous for the N540K mutation </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the 4 patients with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> presented the G1138A mutation </plain></SENT>
<SENT sid="10" pm="."><plain>None of these mutations were found in patients with idiopathic <z:hpo ids='HP_0004322'>short stature</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Chilean patients with hypochondroplasia and <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> have the same mutations described in other ethnic groups </plain></SENT>
<SENT sid="12" pm="."><plain>The identification of mutations in 3 out of 5 patients with hypochondroplasia shows that this analysis is a useful tool for its diagnostic confirmation </plain></SENT>
<SENT sid="13" pm="."><plain>In <z:hpo ids='HP_0004322'>short stature</z:hpo> the molecular study should only be indicated in those cases presenting other clinical and/or radiological features of hypochondroplasia </plain></SENT>
</text></document>